STAAR Surgical Company
STAA
Positions held
Your positionsSTAA isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- STAAR Surgical operates in the growing medical instruments and supplies industry, which is driven by increasing demand for innovative surgical solutions.
- In Q2 2026, STAAR reported a revenue of $93.535 million, maintaining consistent performance with no growth compared to the previous quarter.
- The gross margin improved to 74.5% in Q2 2026, up from 73.6% in Q1 2026.
- The company's high trailing P/E ratio of 276.875 indicates that it may be overvalued compared to its earnings.
- In 2025, STAAR Surgical experienced a significant operating margin decline to -19.19%, reflecting operational challenges.
- The net income for 2025 was -$80.448 million, highlighting ongoing financial struggles.
Fundamentals
| Market cap | $1.12B | Enterprise value | $976.67M | Trailing P/E | 279.75 | Forward P/E | 20.14 |
| PEG | 0.76 | Price / book | 3.07 | Beta | 1.18 | Dividend yield | 0.00% |
| Revenue growth | 111.0% | Earnings growth | — | Gross margin | 76.6% | Operating margin | 10.9% |
| Profit margin | 1.1% | ROE | 1.1% | ROA | 5.6% | Debt / equity | 0.10 |
| Current ratio | 4.67 | Free cash flow | $15.35M | Analyst recommendation | buy | Mean target | $28.00 |
| 52w high | $35.87 | 52w low | $15.59 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $93.5M | $93.5M | $57.8M | $94.7M | $44.3M | — |
| Op margin | 10.8% | 18.6% | -18.9% | 25.8% | -55.8% | — |
| Net income | $8.1M | $5.2M | -$18.3M | $8.9M | -$16.8M | — |
| Gross margin | 74.5% | 73.6% | 75.7% | 82.2% | 74.0% | — |
| Gross profit | $69.7M | $68.9M | $43.7M | $77.9M | $32.8M | — |
| Operating income | $10.1M | $17.4M | -$10.9M | $24.4M | -$24.7M | — |
- Revenue +0% vs prior quarter ($94M vs $94M).
- Gross margin 74.5% (was 73.6% prior quarter).
- Operating margin compressed to 10.8%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $239M | $314M | $322M | $284M | — |
| Op margin | -19.2% | -4.0% | 8.7% | 15.4% | — |
| Net income | -$80.4M | -$20.2M | $21.3M | $39.7M | — |
| Gross margin | 76.2% | 76.3% | 78.4% | 78.5% | — |
| Gross profit | $182M | $240M | $253M | $223M | — |
| Operating income | -$45.9M | -$12.6M | $28.1M | $43.8M | — |
Headlines — positive tone
• [OK · fundamentals] STAAR Surgical jumps on Stifel upgrade citing China growth potential
• [OK · fundamentals] STAAR Surgical Shares Rise After Stifel Upgrade
News
2026-10-08 · STAAR Surgical Names Andrew Pilon as Vice President of Business Development
2026-09-29 · Why Staar Surgical Zoomed Almost 8% Higher on Tuesday
2026-09-29 · STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know
2026-09-29 · Sector Update: Healthcare Stocks Softer Late Afternoon
2026-09-29 · Sector Update: Healthcare
2026-09-29 · STAAR Surgical Shares Rise After Stifel Upgrade
2026-09-29 · STAAR Surgical jumps on Stifel upgrade citing China growth potential
2026-09-29 · Stifel Upgrades STAAR Surgical to Buy From Hold, Adjusts Price Target to $31 From $28
2026-09-26 · STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know
2026-09-25 · Why Staar Surgical Stock Soared Today
Price (daily)
Full chart · RSI · MACD · patterns